Will head steady up to 0.05 over coming months - think should be re-rated to min 100M after this news and more if other deals on table.
Bases of my calculations without knowing any other deals in Announcement to come -
Reading some financial information around this deal ISIS received 25M pending the FDA approval. Also they expect revenues of $60M a year by 2016. This is only in the US.
ANP drugs will surely attract similar interest and hopefully be broader market. Also then we have China and Europe.
The opp is massive for ANP if they get it right without the side effects ISIS drug has.
ANP Price at posting:
14.0¢ Sentiment: ST Buy Disclosure: Held
